JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other psychedelic ...

Could it be New Zealand’s Largest Class Action? A potential landmark consumer rights case alleges Johnson & Johnson sold New Zealanders decongestants containing a “useless” ingredient for nearly 20 ...

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Fiancé star Larissa Dos Santos Lima has been diagnosed with major depressive disorder and is stepping away from social media. A rep for the reality star, 38, named Julia Dickson, announced the news on ...

Johnson was named the SEC Men's Basketball Freshman of the Week for an astounding fourth time, the team announced. He is coming off a monster week for the (16-10 and 5-8) Longhorns, in which he ...

Before Sunday's Super Bowl LIX matchup, Fox Sports aired a special feature highlighting the career of legendary NFL coach Jimmy Johnson. The feature utilized artificial intelligence to create ...

Half of the study group met criteria for AUD in the past year and were evenly divided in terms of those who had or had not experienced a major depressive disorder in the past year. Individuals who ...